Role of flow cytometry in plasma cell neoplasms

Beenu Thakral, Kristy Wolniak, Michael A. Linden

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Plasma cell neoplasms (PCN) are a heterogeneous group of disorders with a spectrum of clinical presentations from asymptomatic monoclonal gammopathy of undetermined significance (MGUS) to smoldering multiple myeloma to symptomatic multiple myeloma (MM). Other less common categories of PCN include AL amyloidosis, POEMS syndrome, and plasma cell leukemia. Typically, the gold standard for diagnosis has been to correlate morphologic assessment with clinical information (hypercalcemia, renal failure, anemia, and lytic bone lesions) and serologic data, including protein and urine electrophoresis with immunofixation, along with serum-free light chain assay data. As technology has improved, especially monoclonal antibody production and instrumentation, multicolor flow cytometry has become an important tool to demonstrate that the plasma cells present in a bone marrow/tissue/fluid specimen are clonal or immunophenotypically abnormal.

Original languageEnglish (US)
Title of host publicationPlasma Cell Neoplasms
Subtitle of host publicationA Morphologic, Cytogenetic and Immunophenotypic Approach
PublisherSpringer International Publishing
Pages101-122
Number of pages22
ISBN (Electronic)9783319109183
ISBN (Print)9783319109176
DOIs
StatePublished - Jan 1 2015

Fingerprint Dive into the research topics of 'Role of flow cytometry in plasma cell neoplasms'. Together they form a unique fingerprint.

  • Cite this

    Thakral, B., Wolniak, K., & Linden, M. A. (2015). Role of flow cytometry in plasma cell neoplasms. In Plasma Cell Neoplasms: A Morphologic, Cytogenetic and Immunophenotypic Approach (pp. 101-122). Springer International Publishing. https://doi.org/10.1007/978-3-319-10918-3_6